Review
Jul 2026
Dendritic Cell Vaccines for Glioblastoma: A Systematic Review and Meta-Analysis Comparing New-Onset and Recurrent Cases.
Dendritic cell-based immunotherapy can enhance survival outcomes in GBM patients, and was found to be more effective in newly diagnosed GBM than in recurrent cases.
Abdulsalam Mohammed Aleid, Ibrahim Abdullah Houlbah, Mohammed Yahya Abutaleb et al.
· Anti-Cancer Agents in Medici... · 0 citations